[Use of acetomepregenol in the treatment of threatened habitual miscarriage].
Monitoring for pregnancy development and treatment efficacy in 104 females treated with acetomepregenol for threatened recurrent abortion at 8 to 16 week of gestation was performed with the use of ultrasonic variations. Ultrasonic criteria characteristic of the aforementioned condition were established. The technique suggested was distinguished by high levels of sensitivity, simplicity, availability and safety for mother and fetus.
A N
AN
Strizhakov
Iu F
IuF
Borisova
T M
TM
Dondukova
I V
IV
Rodionova
M V
MV
Medvedev
D000026:Abortion, Habitual / Q000188:drug therapy*; D000033:Abortion, Threatened / Q000188:drug therapy*; D000328:Adult; D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D011244:Pregnadienediols / Q000627:therapeutic use*; D011247:Pregnancy; D045167:Progesterone Congeners / Q000627:therapeutic use*
D003277:Contraceptives, Oral, Combined; D011244:Pregnadienediols; D045167:Progesterone Congeners; C027475:mepregenol diacetate
Primenenie atsetomepregenola v lechenii ugrozhaiushchego privychnogo vykidysha.